Company Info
| Year Established: | 2010 |
Contacts
| Primary: | Steven Roy, MBA President & CEO |
Company Description
VetDC has developed VDC-1101, a novel drug in development to treat canine lymphoma, one of the most common and deadly cancers affecting dogs and cats.
